MAbTree

Zwingen, Switzerland Founded: 2019 • Age: 7 yrs
Develops innovative monoclonal antibody technologies for cancer treatment.

About MAbTree

MAbTree is a Healthcare company based in Zwingen (Switzerland) founded in 2019. It develops innovative monoclonal antibody technologies for cancer treatment. It operates on a B2B model. Its focus areas include Biotechnology, Medical Research and Cancer Treatments. Its legal entity in India is Mabtree Biologics India Private Limited (U24239TG2019PTC132087).

Company details

MAbTree develops innovative monoclonal antibody technologies for cancer treatment through providing healthcare solutions, advancing biotech innovations, conducting medical research, and cancer treatments. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Indian entity revenue
    ₹41,511

    FY 2023 · -96% YoY

  • Indian entity net loss
    -₹77,054

    FY 2023 · -186% margin

  • Indian entity EBITDA
    ₹25,933

    FY 2023 · 62% margin

Board of directors of Mabtree Biologics India Private Limited (MAbTree)

Mabtree Biologics India Private Limited is the primary company behind MAbTree. The board of Mabtree Biologics India Private Limited currently have 2 directors; the longest-serving is Alexander Ratna Monica, appointed in 2019. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Alexander Ratna Monica
DIN 08546494
Director30 Aug 20197 yrs 2 moMabtree Biologics India Private Limited
Subramanian
DIN 08723399
Director18 Mar 20206 yrs 8 moMabtree Biologics India Private Limited

Financials of MAbTree

Figures of Mabtree Biologics India Private Limited, the primary company behind MAbTree, for FY 2023. Revenue was ₹41,511 (-96% year on year). Net loss was -₹77,054 (-186% margin). EBITDA was ₹25,933 (62% margin). Revenue has grown at a compounded annual rate of -75% over three years.

  • ₹41,511Revenue · FY 2023 · -96% YoY
  • -₹77,054Net loss · -186% margin
  • ₹25,933EBITDA · 62% margin
  • ₹1 LakhPaid-up capital
  • -75%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Mabtree Biologics India Private Limited are on its company page.

Premium access

Detailed financial statements for MAbTree

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MAbTree

MAbTree was founded in 2019.

MAbTree is headquartered in Zwingen, Switzerland. It is registered at Zwingen, Basel-landschaft, Switzerland.

The primary company behind MAbTree, Mabtree Biologics India Private Limited, reported revenue of β‚Ή41,511 for FY 2023, down 96% year on year.

MAbTree develops innovative monoclonal antibody technologies for cancer treatment through providing healthcare solutions, advancing biotech innovations, conducting medical research, and cancer treatments. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

MAbTree operates through Mabtree Biologics India Private Limited.

The legal entities of MAbTree currently have 2 directors, including Alexander Ratna Monica, Subramanian.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available